GlobeNewswire

Olema Oncology Announces Corporate Name Change
12/11/2026
SAN FRANCISCO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Olema Oncology, Inc. (formerly Olema Pharmaceuticals, Inc.) (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the [...]
NeOnc Insider Buying Expands Ahead of FDA Discussions and Two Key Brain Cancer Data Presentations
12/11/2026
New insider filings show continued open-market buying by CEO Amir Heshmatpour, while the company prepares to discuss a potential accelerated approval strategy and Phase 3 trial design with regulators DENVER, Nov. 12, [...]
DaltonTx appoints Melissa Landon as Chief Commercial Officer to drive commercial growth and strategic partnerships
12/11/2026
Dr Landon brings 20+ years of experience in the application of AI/ ML to drug discovery She joins Dalton Tx to drive adoption of Dalton Tx ’s platform across pharma, biotech and CROs LONDON, Nov. 12, 2026 (GLOBE [...]
Commit Biologics nominates first development candidate from BiCE™, its complement system engaging platform, and strengthens senior leadership
12/11/2026
COM002 is a first-in-class complement-powered immune engager based on Commit Biologics’ proprietary BiCE™ platform. Anne-Marie Levy Rasmussen appointed Chief Operating Officer and Dr. Benjamin Ole Wolthers as Head of [...]
A Race Against Blindness Unveils Classic 1989 Toyota Land Cruiser Fundraiser to Advance Vision Research
12/11/2026
Iconic FJ62 Land Cruiser returns with modern upgrades in a $125,000 prize package supporting research for inherited retinal diseases GILBERT, Ariz., Nov. 12, 2026 (GLOBE NEWSWIRE) -- A Race Against Blindness is bringing [...]
Rakovina Therapeutics Expands Strategic Engagement with Renowned AI Drug Discovery Pioneer Dr. Artem Cherkasov
12/11/2026
World leader in AI drug discovery to take on an expanded strategic advisory role, supporting AI drug discovery strategy, technology assessment and corporate development opportunities VANCOUVER, British Columbia, Nov. 12 [...]
Human Appeal USA expands winter coat drive to six states
12/11/2026
Second annual campaign builds on 2,000 coats distributed in Baltimore last year, with plans to engage 40 collection partners and at least 300 volunteers MISSION VIEJO, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Human [...]
Belite Bio Reports Unaudited Third Quarter 2026 Financial Results and Provides a Corporate Update
12/11/2026
New Drug Application (NDA) for tinlarebant in Stargardt disease type 1 (STGD1) granted priority review by the U.S. Food and Drug Administration (FDA) in August 2026 with Prescription Drug User Fee Act (PDUFA) target [...]
Fennec Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
12/11/2026
~ Third Quarter 2026 Net Product Sales of $19.4 Million, Up 56% Year over Year ~ ~ Third Quarter 2026 Non-GAAP Adjusted EBITDA of $5.8 Million ~ ~ With $6.7 Million in Positive Cash Flow from Operations, Cash Position [...]
Santhera Signs Distribution Agreement with SteinCares for AGAMREE® (Vamorolone) in 31 countries across Latin America and the Caribbean
12/11/2026
Pratteln, Switzerland, November 12, 2026 – Santhera Pharmaceuticals (SIX: SANN) announces it has signed an exclusive agreement with SteinCares for the distribution of AGAMREE® (vamorolone) for the treatment of Duchenne [...]
Zealand Pharma Announces Financial Results for the First Nine Months of 2026
12/11/2026
Company announcement – No. 56 / 2026 Zealand Pharma Announces Financial Results for the First Nine Months of 2026 Advancing at pace towards Metabolic Frontier 2030: petrelintide in Phase 3, survodutide moving towards [...]
Mironid strengthens Board and clinical team to support next phase of growth
12/11/2026
Dr. Omar Khwaja joins the Board as Non-Executive Director Senior leadership team further strengthened with the appointments of Lars Erwig and Kimberly Hoffman Glasgow, Scotland, November 12, 2026 – Mironid, a [...]
RAMSAY SANTE obtient l'approbation de l'Australian Securities Exchange pour sa cotation en Australie en tant qu'entité étrangère exemptée
12/11/2026
INFORMATION RÉGLEMENTÉE Paris le 12 novembre 2026 Ramsay Santé obtient l’approbation de l’ Australian Securities Exchange pour sa cotation en Australie en tant qu’entité étrangère exemptée Ramsay Santé annonce aujourd’ [...]
RAMSAY SANTE obtains approval from the Australian Securities Exchange for its foreign exempt listing in Australia
12/11/2026
REGULATORY INFORMATION Paris, November 12, 2026 Ramsay Santé obtains approval from the Australian Securities Exchange for its foreign exempt listing in Australia Ramsay Santé today announces that the Australian [...]
Evosep Appoints Scientia Life Technologies as Distributor in India
12/11/2026
Partnership gives India’s proteomics community more direct access to Evosep solutions, local expertise and support BHUBANESWAR, India , Nov. 12, 2026 (GLOBE NEWSWIRE) -- Evosep today announced the appointment of [...]
Top Outsourcing Medical Billing Services at Remitwright: Denial Management, A/R Recovery, Credentialing, NEMT and Home Care Billing Launch the Company's 2027 Service Line
12/11/2026
The New York medical billing company details the outsourcing medical billing services it is built around, what each one delivers, and how a dedicated billing team changes the result for independent practices. New York [...]
Glass House Brands Announces Change of Auditor
12/11/2026
LONG BEACH, Calif. and TORONTO, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (NYSE: GLAS) today announced that BDO USA, P.C. ("BDO") resigned as auditor [...]
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
11/11/2026
Company Announcement COPENHAGEN, Denmark; November 11, 2026 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]
Lakefront Biotherapeutics Reports Nine Months 2026 Financial Results and Provides Business Update
11/11/2026
Gamgertamig poster accepted for presentation at the 2026 ASH 1 Annual Meeting, featuring data from ongoing Phase 1b studies that suggest potential to retain remission after B cell reconstitution, maintained in the [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum